CardioVascular BioTherapeutics to Present at Wall Street Analyst Forum on September 20.LAS VEGAS -- CardioVascular BioTherapeutics, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :CVBT CVBT Cardiovascular Biotherapeutics, Inc CVBT Central Virginia Battlefields Trust (Fredericksburg, VA Civil War history organization) ) today announced that Dan Montano, the company's Co-President and Chief Executive Officer, will present at the Wall Street Analyst Forum on Thursday, September 20, 2007 at 11:10 a.m. Eastern Time (8:10 a.m. Pacific time). The conference is being held at the Princeton Club in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . Interested parties can access a live audio webcast and slide presentation at www.cvbt.com. An archived presentation will be available on the website for 14 days. About CardioVascular BioTherapeutics CVBT is a biopharmaceutical company developing drug candidates with human Fibroblast fibroblast /fi·bro·blast/ (fi´bro-blast) 1. an immature fiber-producing cell of connective tissue capable of differentiating into chondroblast, collagenoblast, or osteoblast. 2. Growth Factor-1 (FGF-1) as their active pharmaceutical ingredient (API) for diseases characterized by inadequate blood flow to a tissue or organ. The company has three clinical trials underway with drug candidates to treat the following medical indications: severe Coronary Heart Disease coronary heart disease: see coronary artery disease. coronary heart disease or ischemic heart disease Progressive reduction of blood supply to the heart muscle due to narrowing or blocking of a coronary artery (see atherosclerosis). (CVBT-141H), dermal wound healing in diabetics (CVBT-141B), and Peripheral Arterial Disease (CVBT-141C). Source: CardioVascular BioTherapeutics, Inc. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion